To CANCER IMMUNITY Home Page

Table 1

Clinical and pathological characteristics of 21 HCC cases investigateda.

Case No.

Gender

Age

Virus Type

Tumor Dimensions (cm)

Histological Grade

Stage

AFP
(ng/ml)

1

M

62

HBV

5x2x3

poorly differentiated?

I/II

n.a.

2

M

41

HBV

4x2x3

well differentiated

I

50

3

M

52

HBV

2x1x3

well differentiated

I

n.a.

4

M

30

HBV

4.2x3x3

poorly differentiated

I

>1211

5

M

73

HBV

5x4x3

well differentiated

II

473

6

M

50

HBV

3x2x4

well differentiated

II

n.a.

7

M

41

-

n.a.

n.a.

n.a.

<50

8

M

29

HBV

2x2x1

well differentiated

I

<50

9

M

40

HBV

3x2x3

well differentiated

I

n.a.

10

M

57

HBV

3x3x3

poorly differentiated?

II

<50

11

F

16

HBV

8x6x3

poorly differentiated

III

>1600

12

M

65

HBV

6x6x5

moderately differentiated

I/II

380

13

M

47

HBV

11x10x7

well differentiated

II/III

>400

15

M

31

HBV

2.5x3x2

poorly differentiated

III

n.a.

16

M

?

HBV

4x2x2

poorly differentiated

III

<50

20

M

58

HBV

10x9.6x8

poorly differentiated

I/II

>400

21

M

47

HBV

3x2.1x2

well differentiated

I

10

22

M

45

HBV

5x3x3

moderately differentiated

I

<50

23

M

45

HBV

10x9x8

poorly differentiated

I/II

n.a.

24

M

46

-

4x4x4

adenocarcinoma

I

88

25

F

48

HBV

10x8x8

poorly differentiated

I

<50

aAbbreviation: n.a., not available.

 

Copyright © 2002 by Michael Pfreundschuh